Themis Medicare has informed that the Company’s Haridwar Plant has been granted a Certificate by European Union - Good Manufacturing Practice (EU-GMP) for Company’s oral and topical manufacturing sections. With this, the Company can commercialise its products in the European Union (EU) countries. This certification will also give access to the Company to commercialise its products in the Pharmaceutical Inspection Co-operation Scheme (PICS) markets for Company’s products manufactured at Company’s State of-the-Art manufacturing facility at Haridwar.
The above information is a part of company’s filings submitted to BSE.
